• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconEli Lilly

Eli Lilly

Page 5 of 7
PoliticsBiden team, pharmaceutical giant Eli Lilly condemn new Indiana abortion ban: ‘We will be forced to plan for more employment growth outside our home state’
By The Associated PressAugust 6, 2022
HealthThis Nashville-based VC is addressing racial inequalities in health care with a fund backed by Eli Lilly, Cardinal Health, and others
By Blake Farmer and Kaiser Health NewsFebruary 24, 2022
MagazineInsulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
By Geoff ColvinDecember 6, 2021
FinanceEli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial
By Robert Langreth and BloombergAugust 3, 2021
FinanceEli Lilly stock hits all-time high on Alzheimer’s treatment news
By Chris MorrisJune 24, 2021
Juneteenth Black diversity officers health inequality
Leadership3 Black diversity chiefs on how they’ll fight racial inequality in medicine
By Sy MukherjeeJune 18, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
HealthBiogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
HealthMeet the most innovative and inventive pharmaceutical companies of 2021
By Sy Mukherjee and IDEA PharmaApril 16, 2021
HealthEli Lilly is granted emergency approval for COVID-19 antibody drug by the FDA
By Riley Griffin and BloombergNovember 10, 2020
NewslettersStocks, futures slip as even a surge of ‘beats’ fail to lift the COVID gloom
By Bernhard WarnerOctober 27, 2020
HealthEli Lilly’s antibody treatment proves unhelpful for advanced COVID cases
By BloombergOctober 26, 2020
Medical syringe is seen with 'covid-19' sign displayed on a screen in the background in this illustration photo taken in Poland on October 12, 2020.
HealthAs COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By David MeyerOctober 15, 2020
NewslettersInvestors pull back on vaccine jitters and earnings woes
By Bernhard WarnerOctober 14, 2020
Eli Lilly COVID drug cocktail
HealthCOVID treatments like the experimental antibody therapeutic Trump received are making progress
By Sy MukherjeeOctober 7, 2020
General Views of Eli Lilly & Co.
NewslettersEli Lilly is teaching an old drug technology new tricks against COVID—and has promising early results
By Sy MukherjeeSeptember 17, 2020
1...
  • 3
  • 4
  • 5
  • 6
  • 7
7
Most Popular
Economy
Your grandparents are the reason the U.S. isn't in a recession right now. That won't last foreverAn image of a popular article
By Eleanor PringleMarch 1, 2026
Success
MacKenzie Scott's close relationship with Toni Morrison long before Amazon put her on the path give more than $1 billion to HBCUsAn image of a popular article
By Sasha RogelbergMarch 1, 2026
Personal Finance
Trump's universal 401(k) architect on why lower-income people distrust retirement accounts: 'they want to know what the catch is'An image of a popular article
By Jacqueline MunisFebruary 28, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.